Drugs Information and Monitoring System (DIMS)
In 2019, DIMS received more visitors and samples than ever before. The majority of these samples consisted of XTC tablets, many of which contained dangerously high dosages of MDMA. The annual report 2019 covers the concentrations, adulterations, and other relevant information produced by DIMS in the past year, and in doing so forms a topical image of the Dutch drug market.
Spread out over all Dutch provinces, the DIMS network encompasses 33 testing-facilities providing nation-wide coverage. Together with these partners, DIMS aims to create a clear insight into the Dutch drug market, and signal potential health risks to the public.